Please login to the form below
Emma Walmsley
This page shows the latest Emma Walmsley news and features for those working in and with pharma, biotech and healthcare.
GSK and CureVac look to develop next-generation mRNA COVID-19 vaccines
We believe that next generation vaccines will be crucial in the continued fight against COVID-19,” said Emma Walmsley, chief executive officer of GSK.
Latest news
-
GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
GSK’s CEO Emma Walmsley and R&D chief Hal Barron have led the company’s re-entry into oncology, having overseen a number of new additions to the oncology pipeline.
-
GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
GlaxoSmithKline’s chief executive officer Emma Walmsley (pictured above) is ‘optimistic’ that a vaccine against COVID-19 will be widely available in 2021. ... Speaking at the third annual Helen Alexander Memorial Lecture – an online event of the
-
GlaxoSmithKline reportedly looking to sell select antibiotic brands
On a conference call last month, GSK CEO Emma Walmsley said that the company’s “first priority remains… to invest in R&D and future growth drivers”. ... Since the beginning of 2019, GSK and new CEO Walmsley have been trying to reverse that deal
-
GSK considers more divestments to help R&D push
GSK’s chief executive Emma Walmsley (pictured right) reiterated yesterday on a conference call that GSK’s “first priority remains… to invest in R&D and future growth drivers”, adding that
-
FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
ago. GSK’s new CEO Emma Walmsley (pictured left) and new R&D chief Hal Barron have helmed the company’s re-entry into oncology, having overseen a number of new
More from news
Approximately 2 fully matching, plus 50 partially matching documents found.
Latest Intelligence
-
Women Leaders in UK Healthcare: Liz Henderson
It’s also great to see outside Merck that women are also progressing in other companies too – like Emma Walmsley at GSK – which gives women the inspiration that they too can
-
25 Women Leaders in UK Healthcare
10. THEODORA HAROLD . Biotech leader. While big pharma is making some significant strides in having women as their top leaders (most notably GSK’s CEO Emma Walmsley), the biotech sector, particularly
-
Diversity and inclusion in the pharma industry
If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity to Business Insider UK, ‘‘You cannot be a modern employer in an industry that should be future facing and modernising arguably
-
30 Women Leaders in UK Healthcare (part 3)
29. Emma Walmsley, GSK CEO. Emma Walmsley is the first-ever woman leader of a big pharma company, having taken on the CEO role at GlaxoSmithKline in April 2017. ... Since then, Walmsley has very definitely put her own stamp on the firm, making major
-
Pharma deals continue to slide
Emma Walmsley, CEO of GSK, said: “We will use cash for business development purposes, with M&A obviously dependent on the right kind of return profile.”.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
GSK appoints president of global pharmaceuticals
Emma Walmsley, GSK's chief executive officer designate, said: “Luke brings a combination of excellent R&D insight and a strong track record of commercial execution.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Gene Editing and Precision Medicine: The Future of Healthcare?
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
Quick links
Infographics
